Insights from 2023 ASCO® Annual Meeting
Playback speed
10 seconds
ASCO® 2023 Insights: "Results From the Randomized Phase 3 OLIGO Study - High Dose Alkylating Chemo for Pts With Oligometastatic BC Harboring HRD"
108 views
June 16, 2023
Login to view comments.
Click here to Login
Breast